Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 070289/0573 | |
| Pages: | 3 |
| | Recorded: | 02/21/2025 | | |
| Attorney Dkt #: | 201103-US-PCT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18851158
|
Filing Dt:
|
09/26/2024
|
|
Publication #:
|
|
Pub Dt:
|
06/26/2025
| | | | |
|
Title:
|
EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS IN COMBINATION WITH AN AKT INHIBITOR FOR THE TREATMENT OF CANCER
|
|
|
Assignee
|
|
|
|
|
| SE-151 85 |
| SODERTALJE, SWEDEN |
|
|
Correspondence name and address
|
| |
LISA ROBINSON
|
| |
1004 MIDDLEGATE ROAD
|
| |
MISSISSAUGA, L4Y 1M4 CANADA
|
Search Results as of:
08/11/2025 07:12 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
